Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Awards $40.7M to Consortium for Functional Glycomics

NEW YORK (GenomeWeb News) - The National Institute of General Medical has awarded a $40.7 million grant to the Consortium for Functional Glycomics.
The consortium, formed in 2001, will use the funding to support its research into the mechanisms through which carbohydrate-binding proteins mediate cell function.
Since 2001, the consortium has been forming alliances and building resources, such as a glycan array. The second five years will focus on new initiatives, such as creating a pathogen glycan array, developing new technologies to conduct high-throughput glycomics analysis, and creating a reagent bank, the consortium said.
The group represents more than 25 countries, including University of California, Massachusetts Institute of Technology, Palo Alto Research Center, Emory University, Indiana University, Imperial College of London, Japan’s Kyoto University, Russia’s ND Zelinsky Institute of Organic Chemistry, and The Netherlands’ VU University Medical Center.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.